Literature DB >> 160741

The development and evaluation of an ovulation inhibitor (DIAne) containing an antiandrogen.

U Lachnit-Fixson.   

Abstract

The combination of 2 mg cyproterone acetate, a pronounced antiandrogenic substance, in combination with 0.05 mg ethinyl estradiol has undergone intensive multiphasic clinical evaluation. The preparation with the trade name Diane has proven to be not only a reliable contraceptive, but also a very potent drug for the treatment of both acne and seborrhea, and of milder cases of hirsutism. The effect of Diane on markedly increased hair growth was not so pronounced. In addition to the presentation of the most pertinent steps of the clinical investigation of Diane, the possible mode of actions of antiandrogens alone and in combination with an estrogen is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 160741     DOI: 10.3109/00016347909157227

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand Suppl        ISSN: 0300-8835


  4 in total

Review 1.  How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?

Authors:  E Diamanti-Kandarakis
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

2.  [Estrogen and androgen receptors in patients with acne vulgaris (author's transl)].

Authors:  J B Schmidt; J Spona
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

3.  The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.

Authors:  A van Hylckama Vlieg; F M Helmerhorst; J P Vandenbroucke; C J M Doggen; F R Rosendaal
Journal:  BMJ       Date:  2009-08-13

Review 4.  Cyproterone acetate for hirsutism.

Authors:  Z M Van der Spuy; P A le Roux
Journal:  Cochrane Database Syst Rev       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.